Unió Europea - danès - EMA (European Medicines Agency)

novartis europharm limited - rivastigmin - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatisk behandling af mild til moderat alvorlig alzheimers demens. symptomatisk behandling af mild til moderat svær demens hos patienter med idiopatisk parkinsons sygdom.

Unió Europea - danès - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant kan anvendes som monoterapi eller i kombination med methotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Unió Europea - danès - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastiske midler - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Unió Europea - danès - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - leukæmi, myelogen, kronisk, bcr-abl positiv - antineoplastiske midler - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Unió Europea - danès - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - colitis, ulcerativ - immunosuppressiva - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Unió Europea - danès - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastiske midler - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - alanin, arginin, calciumchloriddihydrat, glycin, histidin, isoleucin, leucin, lysinhydrochlorid, magnesiumchloridhexahydrat, methionin, natriumchlorid, natriumlactat, phenylalanin, prolin, serin, threonin, tryptophan, tyrosin, valin - peritonealdialysevæske

Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - alanin, arginin, asparaginsyre, glucose, vandfri, glutaminsyre, glycin, histidin, isoleucin, leucin, lysin, methionin, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, renset, threonin, tryptophan, tyrosin, valin - infusionsvæske, emulsion

Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - alanin, arginin, fiskeolie, rig på omega-3-syrer, glucosemonohydrat, glycin, histidin, isoleucin, leucin, lysinacetat, methionin, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin - infusionsvæske, emulsion

Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - alanin, arginin, calciumchloriddihydrat, fiskeolie, rig på omega-3-syrer, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinacetat, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, phenylalanin, prolin, serin, soyaolie, taurin, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion